The global carrier screening market is predicted to register a CAGR of 10.9% during the forecast period by P&S; Intelligence.

As per a study conducted by P&S; Intelligence, the global carrier screening market reached a value of $1,303.6 million in 2016, and it is predicted to register a CAGR of 10.9% during the forecast period (2020–2030). The market is growing due to the rising number of advanced product launched, increasing availability and affordability of tests, and surging prevalence of genetic diseases across the globe. When type is taken into consideration, the market is divided into targeted carrier screening and expanded carrier screening.

Request for sample copy of this report: https://www.psmarketresearch.com/market-analysis/carrier-screening-market/report-sample

Out of all these, the cystic fibrosis category accounted for the largest revenue share of the carrier screening market during the historical period (2014–2019). The prevalence of this diseases is rising rapidly in North America and Europe. In addition to this, people are increasingly becoming aware regarding this health issue and are understanding the importance of it being diagnosed early. This is resulting in the rising demand for testing for this disease.

When technology is considered, the graphene market is divided into microarray, DNA sequencing, and polyamerase chain reaction. Out of these, the DNA sequencing division is projected to witness the highest CAGR during the forecast period, as the cost of the technology is low. In addition to this, high expertise in the field of bioinformatics is not required for using this technology. In recent years, DAN sequencing is being integrated with a large number of user-friendly tools, thereby making the screening process quite simple.

Browse full report at: https://www.psmarketresearch.com/market-analysis/carrier-screening-market

The prevalence of genetic diseases has been rising rapidly, which is resulting in the growth of the carrier screening market. The severity and risk of genetic disease largely depend on ancestors and parent’s carrier status, owing to which, it is important to screen these diseases early. The American College of Obstetricians and Gynecologists recommend pregnant women to get tested for detecting the risk of such diseases early. Because genetic disease account for a high infant mortality rate, parent are becoming highly concerned regarding their children, which is predicted to drive the market.

Source: Free Articles from ArticlesFactory.com

ABOUT THE AUTHOR

Contact:

Prajneesh Kumar

P&S; Intelligence

Contact: +1-347-960-6455

Email: enquiry@psmarketresearch.com

Web: https://www.psmarketresearch.com